Bioventus, Inc. (BVS)
7.45
-0.25
(-3.25%)
USD |
NASDAQ |
Dec 19, 13:08
Bioventus EPS Diluted (Quarterly): 0.0458 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.3495 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
| Catheter Precision, Inc. | -1.705 |
| Picard Medical, Inc. | -0.1915 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 4.006M |
| Revenue (Quarterly) | 138.65M |
| Total Expenses (Quarterly) | 135.50M |
| Enterprise Value | 855.88M |
| Gross Profit Margin (Quarterly) | 66.95% |
| Profit Margin (Quarterly) | 2.89% |
| Earnings Yield | 1.51% |
| Operating Earnings Yield | 9.59% |
| Normalized Earnings Yield | 2.113 |